Is Merck Stock A Sell After FDA Revokes A Keytruda Approval? 2021-04-30T11:34:47-04:00April 30th, 2021| share this article! Merck stock was under pressure in late April after the company lost approval for Keytruda in late-stage stomach cancer patients. Is Merck stock a sell now? Read More share this article! Related Posts Why Are Xeris Biopharma Shares Moving Monday? – Xeris Biopharma Holdings (NASDAQ:XERS) May 6th, 2024 Why Uniti Group Shares Are Trading Lower – Uniti Group (NASDAQ:UNIT) May 6th, 2024 What’s Going On With GameStop Stock? – GameStop (NYSE:GME) May 6th, 2024 Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday? – Integra Lifesciences (NASDAQ:IART) May 6th, 2024
